Nasdaq Stockholm

Bioextrax AB (publ)

ISIN SE0016276752Filings at the FI

At a glance

Most recent filing on October 30, 2026 — a grant by Hemmeslöv Consulting AB on Oct 29, 2026.

We hold 12 visible filings, going back to October 17, 2022.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 12 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 12. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Hemmeslöv Consulting AB Closely associated: Chair of the board
170,000 SEKGrant
TradedOct 29, 2026FiledOct 30, 2026
Hemmeslöv Consulting AB Closely associated: Chair of the board
144,000 SEKOpen-market buy
TradedJan 13, 2025FiledJan 13, 2025
Håkan Björnberg Board member
17,640 SEKGrant
TradedApr 25, 2024FiledApr 25, 2024
Mohammad Ibrahim Board member
39,995 SEKOption exercise
TradedSep 13, 2023FiledSep 17, 2023
Mats Persson Chair of the board
40,800 SEKOpen-market buy
TradedJul 6, 2023FiledJul 11, 2023